Stuart D. Sender

Aziz Burgy

Arnold B. Calmann

Katherine Ann Escanlar

Stephen R. Auten

Aaron M. Johnson

Jaimin H. Shah

Ricardo S. Camposanto

Amlan Ray

Nicole G. McDonough

Rebecca L. Neubauer

Kelly O'Connor

Sara B. Natour

William C. Baton

Charles M. Lizza

Sarah Ann Sullivan

Andrea W. Jeffries

Matthew J. Hertko

Anthony Insogna

Alexander Lee Callo

Laura Kanouse

Ultragenyx Pharmaceutical Inc

Aurobindo Pharma USA Inc

Navinta LLC

Baylor Research Institute

Esjay Pharma LLC

Esjay Pharma Private Ltd

Last Docket Entry Date

Total Docket Entries

ANDA filings by generic makers trigger Ultragenyx lawsuit to defend its rare disease drug DOJOLVI®, sparking a clash over high-purity `triheptanoin` patents.

2:24-cv-09483 | Ultragenyx Pharmaceutical Inc v. Navinta LLC | Ex Parte

United States District of New Jersey

Name	Ratings
Ultragenyx Pharmaceutical Inc	---- --
Baylor Research Institute	---- --

Name	Ratings
Jones Day	L5A
Anthony Insogna	L5A
Matthew J. Hertko	L5B
Andrea W. Jeffries	L5E
Laura Kanouse	---- --
Saul Ewing LLP	L4B
William C. Baton	L5A
Charles M. Lizza	L5A
Sarah Ann Sullivan	L5A
Alexander Lee Callo	L3C

Name	Ratings
Navinta LLC	---- --
Aurobindo Pharma USA Inc	L5E
Esjay Pharma Private Ltd	---- --
Esjay Pharma LLC	---- --

Name	Ratings
SaiberLocal	L3B
Arnold B. Calmann	L5D
Katherine Ann Escanlar	L5E
Axinn Veltrop Harkrider LLP	L3E
Aziz Burgy	L5E
Ricardo S. Camposanto	L4E
Sara B. Natour	---- --
Sills Cummis Epstein & Gross	L2C
Nicole G. McDonough	---- --
Kelly O'Connor	---- --
Windels Marx Lane Mittendorf	L2E
Stuart D. Sender	L5E
Amlan Ray	---- --
Attorney at LawLocal	---- --
Stephen R. Auten	---- --
Aaron M. Johnson	---- --
Jaimin H. Shah	---- --
Rebecca L. Neubauer	---- --